Intellectual property is arguably the lifeblood of discovery. But as academic scientists increasingly accept industry funding and engage in commercial activities such as patenting, the concern is that biomedical research will suffer as rights holders refuse to share their materials and information. Patents, however, may not be the issue, according to two recent surveys and a new report by the National Academy of Sciences.1
"The problem is not patents per se," says John P. Walsh, associate professor of sociology at the University of Illinois-Chicago. "It's a combination of scientific competition, wanting to publish first, and commercial interests more broadly." Additionally, he points out, many academic scientists tend to largely ignore patents anyway.
In a survey of biomedical researchers conducted in late 2004, Walsh and colleagues found that only 5% of academic bench scientists regularly check for patents on work related to their research. More often, difficulties arise when scientists ask ...
